Simplex Trading
KURA icon

Simplex Trading’s Kura Oncology KURA Stock Holding History

Simplex Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68K Sell
6,200
-58,800
-90% -$555K ﹤0.01% 5981
2026
Q1 		$528K Sell
65,000
-23,000
-26% -$198K ﹤0.01% 3189
2025
Q4 		$914K Sell
88,000
-1,200
-1% -$12.6K ﹤0.01% 2715
2025
Q3 		$789K Buy
+89,200
New +$636K ﹤0.01% 3294
2025
Q2 		– Sell
-10,100
Closed -$66K – 9237
2025
Q1 		$66K Buy
10,100
+9,500
+1,583% +$74K ﹤0.01% 5498
2024
Q4 		$5K Buy
600
+300
+100% +$4.32K ﹤0.01% 7624
2024
Q3 		$5K Hold
300
– – ﹤0.01% 7622
2024
Q2 		$6K Sell
300
-10,900
-97% -$224K ﹤0.01% 7774
2024
Q1 		$238K Buy
11,200
+9,900
+762% +$192K ﹤0.01% 4653
2023
Q4 		$18K Buy
1,300
+900
+225% +$8.85K ﹤0.01% 7006
2023
Q3 		$3K Sell
400
-3,600
-90% -$36.6K ﹤0.01% 7915
2023
Q2 		$42K Buy
+4,000
New +$47.3K ﹤0.01% 6013
2022
Q4 		– Sell
-4,400
Closed -$60K – 9829
2022
Q3 		$60K Buy
4,400
+4,200
+2,100% +$64.8K ﹤0.01% 6187
2022
Q2 		$3K Hold
200
– – ﹤0.01% 9158
2022
Q1 		$3K Sell
200
-17,100
-99% -$247K ﹤0.01% 9713
2021
Q4 		$242K Buy
17,300
+2,000
+13% +$32.4K ﹤0.01% 4895
2021
Q3 		$332K Hold
15,300
– – ﹤0.01% 4738
2021
Q2 		$319K Buy
15,300
+15,219
+18,789% +$378K ﹤0.01% 4875
2021
Q1 		$228K Sell
81
-332
-80% -$10.5K ﹤0.01% 4556
2020
Q4 		$1.35M Buy
413
+381
+1,191% +$13.4K ﹤0.01% 2184
2020
Q3 		$98K Sell
32
-78
-71% -$1.72K ﹤0.01% 4929
2020
Q2 		$179K Buy
110
+87
+378% +$1.25K ﹤0.01% 4117
2020
Q1 		$22K Buy
23
+22
+2,200% +$252 ﹤0.01% 5870
2019
Q4 		$1K Sell
1
-11
-92% -$163 ﹤0.01% 7106
2019
Q3 		$18K Buy
12
+11
+1,100% +$196 ﹤0.01% 5890
2019
Q2 		$1K Sell
1
-5
-83% -$83 ﹤0.01% 6875
2019
Q1 		$9K Sell
6
-104
-95% -$1.6K ﹤0.01% 6213
2018
Q4 		$154K Buy
110
+4
+4% +$53 ﹤0.01% 3430
2018
Q3 		$185K Buy
106
+80
+308% +$1.53K ﹤0.01% 3724
2018
Q2 		$47K Buy
+26
New +$440 ﹤0.01% 5120

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Simplex Trading's KURA Position: Q2 2026 in Review

Simplex Trading sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 6,905 shares — an estimated $65.1K sold.

Simplex Trading first reported a position in KURA in Q2 2018 and held it in 20 quarters. The position peaked at $1.29M in Q3 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Simplex Trading reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 6,905 Kura Oncology shares in Q2 2026, an estimated $65.1K.
  • Simplex Trading first reported a position in Kura Oncology in Q2 2018 and held it in 20 quarters.
  • Simplex Trading's Kura Oncology position peaked at $1.29M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.